Adjuvant chemotherapy benefit for ER-negative isolated local breast cancer recurrences confirmed
medwireNews,
medwireNews: The final analysis of the CALOR trial confirms the disease-free survival (DFS) benefit of adjuvant chemotherapy…
The Final Verdict: Chemotherapy Benefits Estrogen Receptor–Negative Isolated Local Recurrence
Overview of attention for article published in Journal of Clinical Oncology, February 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (56th percentile)
Readers on
- mendeley
- 9 Mendeley